Clinical Trial Update: The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from Ain Shams University evaluates intracoronary adrenaline administered via catheter during primary PCI in STEMI patients to determin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• No-reflow Phenomenon
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Ain Shams University | Conditions: ST Segment Elevation Myocardial Infarction (STEMI), No Reflow Phenomenon | Phase 3 | Status: RECRUITING